IP Library Granted Patent US 8,735,609
Granted Patent B2
US 8,735,609 · App. 13/658,103 · Granted May 27, 2014

Bryostatin analogues, synthetic methods and uses

Inventor: Paul A. Wender (Menlo Park, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,735,609
App. No.
13/658,103
Granted
May 27, 2014
Kind
B2
Abstract

Biologically active compounds related to the bryostatin family of compounds, having simplified spacer domains and/or improved recognition domains are disclosed, including methods of preparing and utilizing the same.

Claims (20)

1. A compound having the structure of Formula I:

wherein:

R 1 and R 2 are independently H, —OH, —OR′, —NH 2 , —NR′, ═CH 2 , ═CHR′, ═O, —R′, halogen, —C(R) 2 —COOR′, —C(R) 2 —COO—C(R) 2 —R′, —C(R) 2 —COO—C(R) 2 —C═CR′, —(CH 2 ) q O(O)CR′ or —(CH 2 ) q CO 2 -haloalkyl where q is 0, 1, 2, 3, 4 or 5, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, optionally substituted alkyl amino, optionally substituted haloalkyl, optionally substituted haloalkoxy, optionally substituted alkylthio, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aralkyl, optionally substituted heteroaralkyl, optionally substituted heteroalkyl, optionally substituted cycloalkyl or optionally substituted cycloheteroalkyl, providing that valency is not violated;

R is H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aralkyl, optionally substituted heteroaralkyl, optionally substituted heteroalkyl, optionally substituted alkyl(cycloheteroalkyl);

R 3 is independently H, —OH, or O(CO)R′;

R 4 is ═CR a R b or CHR c R d ;

R a and R b are independently H, —COOR′, —CONR c R d or R′;

R c and R d are independently H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, (CH 2 ) t CONH 2 R′, or (CH 2 ) t COOR′ where t is 1, 2 or 3;

R 6 is H, or R′;

R′ is optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aralkyl, optionally substituted heteroaralkyl, optionally substituted heteroalkyl, optionally substituted alkyl(cycloheteroalkyl), (CO)R″, or (COO)R″;

R″ is optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aralkyl, optionally substituted heteroaralkyl, optionally substituted heteroalkyl, or optionally substituted alkyl(cycloheteroalkyl);

A is O;

the ring containing A is optionally partially unsaturated, provided that R 4 is not ═CR a R b when the ring carbon to which R 4 is attached is unsaturated;

X 1 , X 2 , and X 3 , are O, and X 4 is C(R 1 ) 2 ;

Y is O;

m is 1;

n is 1; and

p is 1;

and its pharmaceutically acceptable salts thereof;

with the proviso that the compound does not have the structure of Formula A

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 28, 2012
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029372/0902 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2012
From: WENDER, PAUL A.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 029237/0845 →
Continuity (3)
Division 12677608
Provisional Application 60981256 · Oct 19, 2007
Related Publication 20130123518A1 · May 16, 2013